We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Read an overview of the NHS breast screening programme (BSP), and learn how to contact the programme.
The MHRA has today, 26 November 2025, approved inavolisib (Itovebi) for the treatment of adults with a type of breast cancer called HR-positive
This guidance explains what the Sloane Project is and how breast screening units (BSUs) can submit data.
Steps to outline how to improve breast cancer clinical care, outcomes and experience for patients has been sent in a letter to the NHS.
This guidance is aimed at BSP providers, commissioners, organisations and individuals who refer women into the very high-risk programme.
This document explains the NHS breast screening programme for women defined as being at high risk of breast cancer.
Clinical guidelines for healthcare professionals screening women for breast cancer.
Nearly 700,000 women across the country will take part in a world-leading trial to test how AI tools can be used to catch breast cancer cases earlier.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).